SPAC607.07c Antibody

What is SPAC607.07c in fission yeast and why study it with antibodies?

SPAC607.07c is a gene in Schizosaccharomyces pombe (fission yeast), a important model organism for studying eukaryotic cellular processes. While its specific function remains under investigation, antibodies against this protein are valuable tools for characterizing its expression, localization, and interactions.

Methodologically, researchers should approach SPAC607.07c studies within the context of S. pombe as a "micromammal" model organism. Fission yeast shares significant biological features with humans including gene structures, chromatin dynamics, intron prevalence, and regulatory mechanisms for gene expression . Using antibodies against SPAC607.07c enables researchers to investigate its potential role in fundamental processes like cell division, DNA damage response, or stress response pathways that are conserved across eukaryotes.

What experimental techniques can SPAC607.07c antibodies be applied to?

SPAC607.07c antibodies can be utilized in multiple experimental approaches:

For optimal results, researchers should validate each application individually. For instance, when performing western blots, protocols similar to those used for other S. pombe proteins can be adapted, using techniques like SDS-PAGE with 4-20% Tris-glycine polyacrylamide gels and transfer to Immobilon P membranes as described in fission yeast research protocols .

How can I design experiments to investigate SPAC607.07c function in relation to cell cycle regulation?

To investigate potential cell cycle-related functions of SPAC607.07c, researchers should leverage S. pombe's well-characterized cell cycle and uniform morphology. Since fission yeast grows by tip elongation and divides by medial fission with cell diameter remaining relatively unchanged, cell cycle stages can be monitored by measuring cell length .

A comprehensive experimental design should include:

• Synchronization of cell populations using methods like centrifugal elutriation or temperature-sensitive cell cycle mutants

• Time-course sampling for protein extraction followed by western blot analysis with SPAC607.07c antibody

• Parallel samples for RNA extraction to correlate protein levels with transcription

• Comparison between wild-type and cell cycle mutant strains (e.g., cdc mutants)

• Co-immunoprecipitation experiments with known cell cycle regulators like Cdc2, Cdc25, or Wee1

This approach would reveal if SPAC607.07c protein levels fluctuate during the cell cycle and whether it physically interacts with established cell cycle components. Researchers should be particularly attentive to the G2/M transition, which is a major control point in the S. pombe cell cycle .

How can I determine if SPAC607.07c is involved in the DNA damage response pathway?

To investigate SPAC607.07c's potential role in DNA damage response, researchers should design a comprehensive set of experiments using genotoxic agents:

• Treat S. pombe cultures with DNA-damaging agents (e.g., UV radiation, hydroxyurea, methyl methanesulfonate) at various doses and time points

• Extract proteins for western blot analysis with SPAC607.07c antibody to detect changes in expression, mobility shifts indicating post-translational modifications, or degradation

• Perform co-immunoprecipitation followed by mass spectrometry to identify damage-specific interaction partners

• Compare responses in wild-type cells versus strains with mutations in key DNA damage response genes

• Create a SPAC607.07c deletion strain using methods described in genome-wide deletion studies and assess its sensitivity to various genotoxic agents

This approach would provide multiple lines of evidence for SPAC607.07c involvement in DNA damage pathways. Based on findings from large-scale screening studies of S. pombe deletion mutants, sensitivity profiles to different DNA damaging agents can reveal specific pathway associations .

What are the optimal conditions for using SPAC607.07c antibody in Western blotting?

For optimal Western blot results with SPAC607.07c antibody, researchers should consider the following methodological approach:

• Sample preparation:

  • Prepare native or denatured lysates from S. pombe cells

  • For denatured samples, heat in SDS lysis buffer (containing 50 mM Tris-HCl, pH 7.5, 1% SDS, 0.1 M NaH₂PO₄, 1.0% NP-40, 150 mM NaCl, 2 mM EDTA, 50 mM NaF, 100 μM Na₃VO₄, 4 μg of leupeptin/ml)

  • Normalize lysates using bicinchoninic acid assay to ensure equal protein loading

• Gel electrophoresis and transfer:

  • Use 4-20% Tris-glycine polyacrylamide gradient gels for optimal protein separation

  • Transfer proteins to Immobilon P membranes (PVDF) using standard electroblotting methods

• Antibody incubation:

  • Block membrane with 5% non-fat dry milk in TBS-T

  • Incubate with SPAC607.07c antibody at 1:1000 dilution (optimization may be necessary)

  • Use appropriate secondary antibodies conjugated with HRP or fluorescent labels

  • Include loading controls such as anti-Cdc2p PSTAIR antibody (1:5000) or anti-Arp3p

• Detection and quantification:

  • Visualize using enhanced chemiluminescence (ECL) or fluorescence scanning methods

  • For quantitative analysis, use fluorescence-based detection and software like ImageJ

Troubleshooting tip: If background is high or signal is weak, try adjusting antibody concentration, extending washing steps, or using different blocking agents like BSA instead of milk.

What controls are essential when performing immunoprecipitation with SPAC607.07c antibody?

When performing immunoprecipitation with SPAC607.07c antibody, the following controls are essential for valid and interpretable results:

• Negative controls:

  • Pre-immune serum immunoprecipitation to account for non-specific binding

  • IgG isotype control matched to the SPAC607.07c antibody

  • Immunoprecipitation from a SPAC607.07c deletion strain (if available)

• Specificity controls:

  • Peptide competition assay where the antibody is pre-incubated with the antigenic peptide before immunoprecipitation

  • Western blot of immunoprecipitated material to confirm the presence of SPAC607.07c protein

• Input sample:

  • Include analysis of the pre-immunoprecipitation lysate (5-10% of input) to compare with immunoprecipitated fractions

• Positive controls:

  • If possible, include immunoprecipitation with a well-characterized antibody against a known S. pombe protein

  • For tagged versions, perform parallel immunoprecipitation with anti-tag antibodies (HA, Myc) if a tagged version of SPAC607.07c is available

For optimal immunoprecipitation, use the protocol described in fission yeast studies: perform IP for 1 hour on ice followed by 30-minute incubation with protein A-Sepharose, wash six times with NP-40 buffer, and resuspend in sample buffer .

How do I validate the specificity of SPAC607.07c antibody in fission yeast?

Validating antibody specificity is crucial for reliable research outcomes. For SPAC607.07c antibody, implement this comprehensive validation strategy:

• Genetic validation:

  • Compare protein detection between wild-type and SPAC607.07c deletion strains

  • If deletion is lethal, use conditional mutants or regulation systems to modulate expression

• Molecular validation:

  • Test antibody against recombinant SPAC607.07c protein

  • Perform peptide competition assays to confirm epitope specificity

• Cross-reactivity assessment:

  • Test against lysates from related yeast species to determine cross-reactivity

  • Perform Western blots with different S. pombe strains to identify potential non-specific bands

• Application-specific validation:

  • For immunofluorescence, compare staining patterns with GFP-tagged SPAC607.07c

  • For ChIP applications, include IgG controls and known non-target regions

• Reproducibility testing:

  • Compare results across different antibody lots

  • Test specificity using different sample preparation methods

This validation approach is supported by standard practices in antibody characterization used in studies of fission yeast proteins, where both genetic and biochemical methods are employed to ensure specificity .

What factors might contribute to inconsistent results when using SPAC607.07c antibody?

Inconsistent results with SPAC607.07c antibody may arise from several factors that require methodological attention:

• Experimental conditions:

  • Cell growth phase variations: S. pombe protein expression can change dramatically during different growth phases

  • Media composition differences: nutrient availability affects gene expression

  • Temperature fluctuations: S. pombe is sensitive to temperature, which affects protein expression patterns

• Technical factors:

  • Antibody storage and handling: repeated freeze-thaw cycles may reduce activity

  • Batch-to-batch variations in antibody production

  • Protein extraction methods: different lysis buffers may affect epitope accessibility

• Biological factors:

  • Post-translational modifications of SPAC607.07c may mask epitopes

  • Protein complex formation may sequester antibody binding sites

  • Protein degradation during sample preparation

• Detection system variations:

  • Inconsistent development times in chemiluminescence detection

  • Variable exposure settings in imaging systems

To address these issues, researchers should establish standardized protocols including consistent cell culture conditions, protein extraction methods, and detection parameters. Additionally, incorporating appropriate controls in each experiment will help identify sources of variability .

How can I use SPAC607.07c antibody to study protein-protein interactions in fission yeast?

To study protein-protein interactions involving SPAC607.07c, researchers can employ several complementary approaches:

• Co-immunoprecipitation (Co-IP):

  • Perform immunoprecipitation with SPAC607.07c antibody under native conditions

  • Analyze co-precipitated proteins by mass spectrometry or western blotting with antibodies against suspected interaction partners

  • Use crosslinking agents like formaldehyde or DSP (dithiobis[succinimidyl propionate]) to capture transient interactions

  • Include appropriate controls as outlined in question 3.2

• Reciprocal Co-IP:

  • Perform immunoprecipitation with antibodies against suspected interaction partners

  • Probe for SPAC607.07c in the immunoprecipitates by western blotting

• Proximity-based labeling:

  • Generate BioID or TurboID fusions with SPAC607.07c

  • Use the SPAC607.07c antibody to confirm expression and localization of the fusion protein

  • Identify proximal proteins using streptavidin pulldown followed by mass spectrometry

• Two-hybrid validation:

  • Use yeast two-hybrid or split-ubiquitin assays to test direct interactions

  • Validate positive interactions by Co-IP with SPAC607.07c antibody

This methodological approach has been successful in identifying protein complexes in S. pombe, such as studies that identified components of the anaphase-promoting complex (APC) through a combination of genetic and biochemical approaches .

How do I integrate SPAC607.07c antibody data with genomic and phenotypic data from fission yeast studies?

Integrating antibody-derived protein data with genomic and phenotypic information requires a multi-layered analytical approach:

• Correlation with transcriptomics:

  • Compare SPAC607.07c protein levels (detected by western blot) with mRNA expression data

  • Analyze whether post-transcriptional regulation might be occurring if protein and mRNA levels don't correlate

• Phenotypic association:

  • Connect SPAC607.07c protein expression/localization patterns with phenotypic data from deletion or mutation studies

  • Utilize the extensive phenomics datasets available for S. pombe, such as the 103,520 quantitative phenotype datapoints for 3492 non-essential genes across 131 diverse conditions

• Network analysis:

  • Place SPAC607.07c in protein interaction networks using immunoprecipitation data

  • Use bioinformatics tools to identify enriched biological processes in the SPAC607.07c interactome

• Functional prediction validation:

  • Test predictions from machine learning approaches like NET-FF that combine protein-network and protein-family data

  • Use SPAC607.07c antibody to experimentally validate these predictions

• Cross-species comparison:

  • Compare SPAC607.07c function with orthologs in other organisms

  • Use the antibody to test conservation of interactions or regulatory mechanisms

This integrative approach aligns with recent studies in S. pombe that combine phenomics data and machine learning predictions to generate functional annotations, as demonstrated in recent large-scale functional profiling efforts .

What are the common challenges in detecting low-abundance SPAC607.07c protein and how can they be addressed?

Detecting low-abundance proteins like SPAC607.07c can be challenging. Here are methodological solutions to common problems:

• Insufficient sensitivity in standard western blots:

  • Enrich the protein using immunoprecipitation before western blotting

  • Use high-sensitivity ECL substrates or fluorescent detection systems

  • Implement signal amplification methods like tyramide signal amplification

  • Consider using PVDF membranes with smaller pore size (0.2 μm) for better protein retention

• High background obscuring specific signals:

  • Optimize blocking conditions (try 5% BSA instead of milk if phosphoproteins are involved)

  • Increase washing duration and frequency

  • Use more dilute antibody solutions with longer incubation times at 4°C

  • Consider monovalent Fab fragments for secondary detection if steric hindrance is suspected

• Protein degradation during extraction:

  • Add multiple protease inhibitors to extraction buffers

  • Perform extraction at 4°C and process samples quickly

  • Use denaturing conditions immediately upon cell lysis

  • Consider crosslinking approaches to stabilize protein complexes

• Low expression under standard conditions:

  • Analyze SPAC607.07c expression under various stress conditions or cell cycle stages

  • Use techniques from studies of other low-abundance fission yeast proteins, which show that protein levels can fluctuate significantly under different growth conditions

• Signal verification:

  • Use epitope-tagged versions of SPAC607.07c (if function is preserved) as positive controls

  • Consider 35S-labeling of proteins as described in fission yeast protocols for enhanced detection sensitivity

How should data inconsistencies between SPAC607.07c antibody results and genetic studies be resolved?

When antibody-based results contradict genetic findings, a systematic approach is required:

• Verify antibody specificity:

  • Reconfirm antibody specificity using methods described in question 4.1

  • Test multiple antibody lots or sources if available

  • Consider generating new antibodies against different epitopes of SPAC607.07c

• Evaluate technical variables:

  • Assess whether differences in experimental conditions might explain discrepancies

  • Review sample preparation methods for potential artifacts

  • Check for post-translational modifications that might affect antibody recognition

• Consider biological complexity:

  • Investigate if SPAC607.07c might have different isoforms or undergo processing

  • Examine if the genetic manipulation might trigger compensatory mechanisms

  • Test if the protein has different functional states not all detectable by the antibody

• Design reconciling experiments:

  • Create an epitope-tagged version of SPAC607.07c and compare detection by tag-antibody versus SPAC607.07c-specific antibody

  • Perform rescue experiments in deletion strains with wild-type or mutant proteins

  • Use orthogonal methods like mass spectrometry to verify protein presence and modification state

• Integrate with other data types:

  • Compare with RNA-seq data to check transcript levels

  • Use proteomic approaches to quantify protein independent of the antibody

  • Consider chromatin association data if SPAC607.07c has potential nuclear functions

How might SPAC607.07c antibody be used to investigate stress response pathways in fission yeast?

SPAC607.07c antibody offers valuable opportunities for investigating stress response pathways through these methodological approaches:

• Stress-induced expression profiling:

  • Expose S. pombe cultures to various stressors (oxidative, heat, osmotic, nutrient deprivation)

  • Perform time-course sampling and western blotting with SPAC607.07c antibody

  • Correlate protein levels with stress response genes

  • Compare wild-type responses with deletion mutants of known stress response pathways

• Subcellular relocalization studies:

  • Use immunofluorescence with SPAC607.07c antibody to track potential stress-induced relocalization

  • Perform subcellular fractionation followed by western blotting to biochemically confirm localization changes

  • Implement live-cell imaging with tagged versions to validate antibody findings

• Post-translational modification analysis:

  • Use phospho-specific antibodies or mobility shift assays to detect stress-induced modifications

  • Perform immunoprecipitation with SPAC607.07c antibody followed by mass spectrometry to identify modifications

  • Compare modification patterns across different stress conditions

• Protein complex remodeling:

  • Investigate how stress affects SPAC607.07c-containing protein complexes

  • Use sequential immunoprecipitation to isolate condition-specific complexes

  • Apply proximity labeling approaches to identify stress-specific interaction partners

This research direction is supported by large-scale phenotypic studies of fission yeast that have identified genes involved in various stress responses , providing a framework for investigating SPAC607.07c's potential role in these pathways.

What emerging technologies could enhance SPAC607.07c antibody applications in fission yeast research?

Several emerging technologies could significantly advance SPAC607.07c antibody applications:

• Advanced microscopy techniques:

  • Super-resolution microscopy (STORM, PALM, SIM) with SPAC607.07c antibody for precise localization

  • Expansion microscopy to physically enlarge samples for improved spatial resolution

  • Correlative light and electron microscopy (CLEM) to connect protein localization with ultrastructural context

• Single-cell proteomics integration:

  • Mass cytometry (CyTOF) with metal-conjugated SPAC607.07c antibodies for single-cell protein quantification

  • Microfluidic antibody-based single-cell western blotting

  • Integration with single-cell transcriptomics for multi-omic analysis

• In situ protein analysis:

  • Proximity ligation assays to visualize protein-protein interactions in fixed cells

  • CODEX or MIBI for highly multiplexed antibody imaging

  • In situ protein sequencing technologies to map protein neighborhoods

• Engineered antibody derivatives:

  • Nanobodies or single-chain antibody fragments for improved penetration in imaging applications

  • Split-protein complementation systems combined with antibody-based targeting

  • Antibody-directed protein degradation systems for acute functional studies

• Computational integration:

  • Machine learning approaches to analyze complex antibody-based imaging data

  • Integration with AlphaFold2-predicted structures to map epitopes and interaction interfaces

  • Network biology tools to place SPAC607.07c in functional contexts based on antibody-derived interaction data

This forward-looking approach aligns with the trajectory of yeast research toward more integrated, high-resolution studies of protein function in cellular contexts, as evidenced by recent advances in functional genomics studies in S. pombe .